Gutted Cambridge biotech declares bankruptcy after failed merger, layoffs


It's (almost) the end for Infinity Pharmaceuticals. Following a failed merger agreement and layoffs that left the company with just three employees, the Cambridge biotech has declared bankruptcy.

Previous Survey: The importance of value and equity in health care
Next JBG Smith opens rebooted Crystal City Water Park with 9 new eateries